March 23, 2015

CPTR Marks Fifth Anniversary, Launches New Website reflects partnership, progress, and perspectives from global thought leaders
March 23, 2015

TB Alliance Announces Partnership with U.S. Fund for UNICEF to Increase Access to Impending New Child-Friendly TB Treatments

Collaboration seeks to pull more sick children out of the shadows and into treatment for tuberculosis
March 17, 2015

The Lancet: Results of Phase 2b Trial of Novel TB Regimen PaMZ Show Potential to Shorten, Improve TB Treatment

Phase 3 STAND Trial Launches to Advance PaMZ through Final Stage of Testing
February 17, 2015

TB Alliance Advances Next-generation TB Drug Candidate into Clinical Testing

TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years
January 28, 2015

Phase 2a Published Results Show the Potential of a New TB Regimen with Novel Drugs Bedaquiline and Pretomanid (PA-824)

Results of study testing BPaZ published in American Journal of Respiratory and Critical Care Medicine; Regimen now being tested in Phase 2b clinical trial
October 21, 2014

TB Alliance Launches Phase 2B Clinical Trial of a Novel TB Drug Regimen that Could Cut Treatment Time by Half or More for a Majority of TB Patients

NC-005 trial tests a novel regimen of bedaquiline (Sirturo), pretomanid (formerly known as PA-824), and pyrazinamide; results could pave the way for a three-month TB treatment